标题
PM00104 (Zalypsis®): A Marine Derived Alkylating Agent
作者
关键词
-
出版物
MOLECULES
Volume 19, Issue 8, Pages 12328-12335
出版商
MDPI AG
发表日期
2014-08-15
DOI
10.3390/molecules190812328
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis
- (2014) Victoria Moneo et al. BMC CANCER
- Phase II clinical trial of PM00104 (Zalypsis®) in urothelial carcinoma patients progressing after first-line platinum-based regimen
- (2014) Daniel E. Castellano et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I study of carboplatin in combination with PM00104 (Zalypsis®) in patients with advanced solid tumors
- (2014) Ramón Salazar et al. INVESTIGATIONAL NEW DRUGS
- A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors
- (2013) J. Capdevila et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors
- (2013) Robin L. Jones et al. INVESTIGATIONAL NEW DRUGS
- Phase II study of weekly PM00104 (ZALYPSIS®) in patients with pretreated advanced/metastatic endometrial or cervical cancer
- (2013) Lainie P. Martin et al. MEDICAL ONCOLOGY
- First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours
- (2012) T A Yap et al. BRITISH JOURNAL OF CANCER
- Population Pharmacokinetic–Pharmacodynamic Analysis of Neutropenia in Cancer Patients Receiving PM00104 (Zalypsis®)
- (2012) Mario González-Sales et al. CLINICAL PHARMACOKINETICS
- Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors
- (2012) Christophe Massard et al. INVESTIGATIONAL NEW DRUGS
- Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response
- (2011) E. Colado et al. HAEMATOLOGICA
- Chromone and Flavonoid Alkaloids: Occurrence and Bioactivity
- (2011) Shahriar Khadem et al. MOLECULES
- Molecular pharmacology and antitumor activity of Zalypsis ® in several human cancer cell lines
- (2009) Juan F.M. Leal et al. BIOCHEMICAL PHARMACOLOGY
- Zalypsis (PM00104) is a potent inducer of -H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition
- (2009) J. Guirouilh-Barbat et al. MOLECULAR CANCER THERAPEUTICS
- The present and future burden of urinary bladder cancer in the world
- (2009) Martine Ploeg et al. WORLD JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started